"I think the most famous existential crisis in Oncology is when a patient asks to be put on some new treatment still in trials, after it's been deemed his mortality is inevitable. There is a reason for studies to be randomized, double-blinded, etc., and it's to advance the science. If he or she were in such a study, I would be unwavering in following the rules. If he or she were not in the study, I would offer to write a letter to the institution and it's Investigational Review Board for a special provision for this patient, with the understanding that his or her response to therapy could not be part of the study. If they denied the request, there's nothing more I could do in this respect."